IN THIS ISSUE .
December 19, 2007
Check out the Biomedical Beat Cool Image Gallery.
Got research news to share? E-mail us at email@example.com.
To change your subscription options or unsubscribe, visit https://public.govdelivery.com/accounts/USNIGMS/subscriber/new?topic_id=USNIGMS_3.
Subscribe to the RSS version of Biomedical Beat by selecting this XML link and following your news reader's instructions for adding a feed.
The National Institute of General Medical Sciences (NIGMS),
one of the National Institutes of Health, supports all research
featured in this digest. Although only the lead scientists
are named, coworkers and other collaborators also contributed
to the findings. To read additional news items, visit NIGMS
News. To check out free NIGMS publications, go to
the order form.
The wreath-like structure formed by a plant pathogen protein inspired a team of structural biologists to dress it up for the holidays. The structure, whose function is unknown, is the first to represent a region shared by a family of proteins. It's among more than 2,700 protein structures generated by the Protein Structure Initiative—an international effort to make the shapes of nearly all proteins readily available from their DNA sequences. Courtesy of Ken Schwinn and Sonia Espejon-Reynes, New York SGX Research Center for Structural Genomics.
New York SGX Research Center for Structural Genomics home page (not available)
Protein Structure Initiative home page
Cholera bacteria accumulate in human intestines until they’ve overpopulated their surroundings and expel themselves from their hosts by triggering severe vomiting and diarrhea. When the bacteria decide to leave and how they broadcast the "abandon ship" command has remained a mystery. Until now. Molecular biologist Bonnie Bassler and colleagues at Princeton University have identified and manufactured the chemical signal, CAI-1, that tells cholera to evacuate the host. The research team’s next step: to see if the molecule cures cholera in laboratory mice. The work could point to new ways of treating cholera and other diseases caused by bacteria that use similar communication strategies.
This work also was supported by NIH's National Institute of Allergy and Infectious Diseases.
When we go to sleep at night, our bodies have a chance to unwind. Our DNA may be doing the same thing. Vanderbilt University biologist Carl Johnson has discovered that the DNA of tiny blue-green algae—a simple organism with a biological clock—is coiled tightly during the day and more relaxed at night. This pattern allows certain genes to change their activity in light or darkness, essentially helping the organism tell time and suggesting why biological clocks influence so many biochemical processes. Although more research needs to be done, Johnson speculates that human DNA may also wind and unwind according to time of day.
Health authorities at the site of an infectious disease outbreak have a new tool to help them track cases and speed the implementation of interventions. By downloading a free software program called TranStat, they can systematically enter and store disease-related data about infected individuals and their close contacts. The program, developed by Ira Longini of the Fred Hutchinson Cancer Research Center and Diane Wagener of RTI International, also calculates the probability of person-to-person transmission. Such information could help health officials develop and swiftly implement strategies that thwart further spread while they conduct additional studies.
Hailed as a scientific breakthrough, University of Wisconsin-Madison cell biologist James Thomson has used human skin cells to create ones that appear to be indistinguishable from embryonic stem cells. Thomson reset the skin cells to the embryonic state by supplying them with four genes, giving them the potential to become any of the 220 cell types in the body. The new technique is expected to bring stem cells within easier reach of more scientists, providing them with better models for studying many human diseases and possibly speeding the advent of cell-based therapies for conditions such as diabetes and arthritis.
This work also was supported by NIH's National Center for Research Resources.